שווי מתואם לחוב ומזומנים journeymedicalcorp.com (DERM)

Journey Medical (DERM) generates revenue through the sale of prescription therapies for rosacea and acne via pharmacy retail. The business relies on significant influence within US medical circles and strict compliance with FDA standards. This chart reflects the current market value on the GURU.Markets platform at 139.90, confirming the brand's stable position driven by exclusive patents and the trust of specialized professionals.

Scaling sales of the Emrosi drug and expanding the dermatological portfolio of Journey Medical (DERM) directly impact the business's investment attractiveness. The company's EV, which combines market capitalization with net debt, reflects the total acquisition cost of the asset, allowing investors to distinguish fundamental value growth from speculative overheating by analyzing the dynamics of this metric on the chart.